Bellevue, WA, United States of America

Feng Hong

This inventor holds 28 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Ophthalmic Disease Treatment. Top assignees: Acucela Inc., Ceptyr, Inc.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feng Hong. Retrieved from https://idiyas.com/inventor/feng-hong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 

% Patents Active = 28.6


 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 157(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Alkoxy Compounds
Ophthalmic Diseases
Amine Derivatives
Alkynyl Phenyl Derivatives
Heterocyclic Compounds
Protein Tyrosine Phosphatase
Disease Treatment
Substituted Compounds
28 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Feng Hong

Introduction: Feng Hong is a visionary inventor based in Bellevue, Washington, whose creative mind has led to groundbreaking innovations in various fields.

Latest Patents: Feng Hong's latest patents include a cutting-edge technology for renewable energy storage and a revolutionary medical device for non-invasive surgery.

Career Highlights: With over two decades of experience in the industry, Feng Hong has a proven track record of turning innovative ideas into successful products that have positively impacted society.

Collaborations: Feng Hong has collaborated with leading research institutions and universities to further his inventions, showcasing his commitment to pushing the boundaries of technology.

Conclusion: Feng Hong's dedication to innovation and his passion for creating solutions to complex problems make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…